W

Waystar Holding Corp
NASDAQ:WAY

Watchlist Manager
Waystar Holding Corp
NASDAQ:WAY
Watchlist
Price: 24.61 USD 0.16% Market Closed
Market Cap: $4.7B

Waystar Holding Corp
Investor Relations

Waystar Holding Corp. sits at the intersection of healthcare and technology, quietly revolutionizing the financial infrastructure of the medical industry. Born from a merger of two industry stalwarts, Navicure and ZirMed, Waystar has gained a reputation for offering comprehensive revenue cycle management solutions. The company's primary mission is to simplify and streamline the healthcare reimbursement process, an area historically fraught with complexity and inefficiency. By leveraging advanced cloud-based technology and a suite of intelligent tools, Waystar enables healthcare providers to process claims, track payments, and manage denials with unprecedented efficiency, thus reducing administrative costs and improving financial outcomes.

Financially, Waystar thrives by licensing its innovative platform to a broad range of healthcare providers, from sprawling hospital systems to smaller clinics and physician groups. These subscriptions are often based on the scale and complexity of the healthcare entities' needs, providing Waystar with a steady stream of predictable revenue. Additionally, the company capitalizes on transaction-based fees from clearinghouse operations, fiduciary in facilitating billions of dollars in healthcare transactions. By embedding itself as an essential cog in the healthcare revenue machinery, Waystar not only ensures its financial health but also sets the benchmark for technological advancement in an industry increasingly reliant on digital solutions.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 17, 2026
AI Summary
Q4 2025

Revenue Milestone: Waystar crossed $1 billion in annual revenue for the first time in 2025, with Q4 revenue of $304 million, up 24% year-over-year.

Guidance Beat: The company exceeded both revenue and EBITDA guidance for the year, with strong subscription and volume-based revenue growth.

AI Momentum: Roughly 30% of new bookings in 2025 came from AI-powered capabilities, and 35% of bookings in Q4 were AI-related.

Iodine Acquisition: The Iodine Software acquisition added over 1,000 hospitals, expanded the addressable market, and is ahead of integration plans, with over 90% of cost synergies expected to be realized in 2026.

Profitability: Adjusted EBITDA margin hit 43% in Q4, above the long-term 40% target, and conversion to unlevered free cash flow remained strong at 79%.

2026 Outlook: Guidance for 2026 is $1.274–$1.294 billion in revenue (17% YoY growth) and $530–$540 million in adjusted EBITDA (16% YoY growth), with normalized organic growth targeted at ~10%.

Client Wins: Win rates improved beyond the historical 80% average, with 85 new large clients added in Q4, and record bookings signaling strong demand.

Key Financials
Revenue
$304M
Revenue (Full Year)
$1.1B
Organic Revenue Growth (Q4)
12%
Organic Revenue Growth (Full Year)
13%
Adjusted EBITDA
$129M
Adjusted EBITDA Margin
43%
Adjusted EBITDA (Full Year)
$462M
Adjusted EBITDA Margin (Full Year)
42%
Subscription Revenue (Q4)
$168M
Subscription Revenue (Full Year)
$558M
Volume-based Revenue (Q4)
$134M
Volume-based Revenue (Full Year)
$535M
Gross Margin (2025 and Guidance)
68%
Unlevered Free Cash Flow (Q4)
$80M
Unlevered Free Cash Flow (Full Year)
$365M
Adjusted EBITDA to Unlevered Free Cash Flow Conversion
79%
Net Leverage (End of Q4)
3x
Net Revenue Retention
112%
Gross Revenue Retention
97%
Clients >$100K LTM Revenue
1,391
Iodine Revenue (Q4)
$31M
Cost Synergies (Iodine)
$14M expected in 2026
Earnings Call Recording
Other Earnings Calls

Management

Mr. Matthew J. Hawkins
CEO & Director
No Bio Available
Mr. Eric L. Sinclair III
Chief Business Officer
No Bio Available
Mr. T. Craig Bridge
Chief Transformation Officer
No Bio Available
Mr. Steven M. Oreskovich CPA
Chief Financial Officer
No Bio Available
Mr. Christopher L. Schremser
Chief Technology Officer
No Bio Available
Mr. Matthew R. A. Heiman
Chief Legal & Administrative Officer
No Bio Available
Mark Encinger
Vice President of Treasury & Compliance
No Bio Available
Ms. Melissa F. Miller
Chief Marketing Officer
No Bio Available
Mr. Brendan O'Connor
Senior Vice President of Corporate Development & Strategy
No Bio Available
Ms. Kim Wittman
Chief People Officer
No Bio Available

Contacts

Address
UTAH
Lehi
1550 Digital Drive, No. 300
Contacts
+18444929782
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett